期刊文献+

PADRE/MUC4重组腺病毒转染树突状细胞诱导特异性CTL体外杀伤作用研究

Generation and cytotoxic analysis of PADRE/MUC4 specific CTL elicited by DC infected with recombinant adenovirus in vitro
下载PDF
导出
摘要 目的:观察PADRE/MUC4重组腺病毒转染树突状细胞(DC)诱导特异性细胞毒性T细胞(CTL)及体外特异性杀伤作用。方法:pAd-CMV-PADRE/MUC4转染HLA-A2健康志愿者外周血单个核细胞(PBMC)来源的未成熟DC,TNF-α诱导成熟后与自体PBMC混合培养刺激3周,Cr51和Elispot实验检测CTL体外杀伤活性。结果:Cr51和Elispot检测结果显示PADRE/MUC4转染DC可以诱导产生特异性CTL,而pAd-CMV-GFP组和空白对照组不能产生有效特异性CTL。结论:腺病毒载体介导多表位嵌合基因(PADRE/MUC4)转染未成熟DC,在体外可以诱导产生特异性CTL,对表达MUC4肿瘤细胞具有杀伤效应。 Objective:To discuss the cytotoxic activity of CTL,stimulated by adenovirus containing the universal DR-restricted Th helper epitope(PADRE) combined with HLA-A1 and HLA-A2 restricted epitopes from mucin4 gene(PADRE/MUC4) infected DCs. Methods:Recombinant adenovirus with PADRE/MUC4 gene was prepared,DCs of HLA-A2 positive donors were induced from PBMC in vitro. PBMC primed with adenovirus infected DC for 3 weeks,the specific cytotoxic activity of CTL was detected by standard 4 h Cr^51 release assay and Elispot method. Results:Lymphocytes primed with pAd-CMV-PADRE/MUC4 caused potent cytotoxic responses. By contrast,lymphocytes primed with a GFP expressing adenovirus or mock-infected DCs had no cytotoxic effect. Conclusion:Infection of DCs with an adenovirus encoding PADRE combined with epitopes from mucin4 gene may be one possible strategy for immunotherapy of MUC4-expressing tumors.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2007年第12期1349-1352,F0002,共5页 Journal of Nanjing Medical University(Natural Sciences)
基金 国家自然科学基金资助项目(30500492和30471691)
关键词 PADRE/MUC4 腺病毒 树突状细胞 细胞毒性T淋巴细胞 PADRE/MUC4 adenovirus dendritic cell cytotoxic T lymphocytes
  • 相关文献

参考文献13

  • 1Nardin E H, Calvo-Calle JM, Oliveira GA,et al. A totally synthetic polyoxime malaria vaccine containing Plasmodium falciparum B cell and universal T cell epitopes elicits immune responses in volunteers of diverse HLA types[J]. Immunol,2001,166( 1 ) :481-489.
  • 2Fong L,Engleman EG. Dendritic cells in cancer immunotherapy [ J ]. Annu Rev Immunol, 2000, 18 : 245- 273.
  • 3Kutzler MA,Weiner DB. Developing DNA vaccines that call to dendritic cells [J]. Clin Invest,2004,114:1241- 1244.
  • 4Dakappagari NK,Pyles J,Parihar R,et al. A chimeric multi-human epidermal growth factor receptor-2 B cell epitope peptide vaccine mediates superior antitumor responses [ J ]. Immunol, 2003,170: 4242-4253.
  • 5Sidney J, Grey HM, Kubo RT, et al. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs [J]. Immunol Today, 1996, 17:261- 266.
  • 6Kwon K,Ro J,Singhal N,et al. MUC4 expression in nonsmall cell lung carcinomas:relationship to tumor histology and patient survival[J]. Arch Pathol Lab Med,2007,131: 593-598.
  • 7Chauhan S, Singh A, Ruiz F, et al. Aberrant expression of MUC4 in ovarian carcinoma:diagnostic significance alone and in combination with MUC1 and MUC16 (CA125) [J]. Mod Pathol,2006, 19:1386-1394.
  • 8Brossart P, Heinrich K,Stuhler G,et al. Identification of HLA-A2-Restricted T cell epitopes derived from the MUC1 tumor antigen for broadly applicable vaccine therapies [ J ]. Blood, 1999,93 : 4309-4317.
  • 9Heiser A, Dahm P, Yancey D, et al. Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTL responses in vitro [J]. Immunol, 2000,10: 5508-5514.
  • 10Pan Y,Zhang J,Zhou L,et al. In vitro anti-tumor immune response induced by dendritic cells transfected with EBVLMP2 recombinant adenovirus [J]. Biochem Biophys Res Commun, 2006,347 : 551-557.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部